Market Research Logo

Biotie Therapies Corp. - Product Pipeline Review - 2015

Biotie Therapies Corp. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Biotie Therapies Corp. - Product Pipeline Review - 2015’, provides an overview of the Biotie Therapies Corp.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Biotie Therapies Corp.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Biotie Therapies Corp. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Biotie Therapies Corp.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Biotie Therapies Corp.’s pipeline products
Reasons to buy
  • Evaluate Biotie Therapies Corp.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Biotie Therapies Corp. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Biotie Therapies Corp.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Biotie Therapies Corp. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Biotie Therapies Corp.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Biotie Therapies Corp. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


Biotie Therapies Corp. Snapshot
Biotie Therapies Corp. Overview
Key Information
Key Facts
Biotie Therapies Corp. - Research and Development Overview
Key Therapeutic Areas
Biotie Therapies Corp. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Biotie Therapies Corp. - Pipeline Products Glance
Biotie Therapies Corp. - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Biotie Therapies Corp. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Biotie Therapies Corp. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Biotie Therapies Corp. - Drug Profiles
tozadenant
Product Description
Mechanism of Action
R&D Progress
BTT-1023
Product Description
Mechanism of Action
R&D Progress
SYN-120
Product Description
Mechanism of Action
R&D Progress
Biotie Therapies Corp. - Pipeline Analysis
Biotie Therapies Corp. - Pipeline Products by Target
Biotie Therapies Corp. - Pipeline Products by Route of Administration
Biotie Therapies Corp. - Pipeline Products by Molecule Type
Biotie Therapies Corp. - Pipeline Products by Mechanism of Action
Biotie Therapies Corp. - Recent Pipeline Updates
Biotie Therapies Corp. - Dormant Projects
Biotie Therapies Corp. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
buprenorphine hydrochloride
AWD-12281
nitisinone
rufinamide
vepalimomab
Biotie Therapies Corp. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Biotie Therapies Corp., Key Information
Biotie Therapies Corp., Key Facts
Biotie Therapies Corp. - Pipeline by Indication, 2015
Biotie Therapies Corp. - Pipeline by Stage of Development, 2015
Biotie Therapies Corp. - Monotherapy Products in Pipeline, 2015
Biotie Therapies Corp. - Out-Licensed Products in Pipeline, 2015
Biotie Therapies Corp. - Out-Licensed Products/ Combination Treatment Modalities, 2015
Biotie Therapies Corp. - Phase III, 2015
Biotie Therapies Corp. - Phase II, 2015
Biotie Therapies Corp. - Preclinical, 2015
Biotie Therapies Corp. - Pipeline by Target, 2015
Biotie Therapies Corp. - Pipeline by Route of Administration, 2015
Biotie Therapies Corp. - Pipeline by Molecule Type, 2015
Biotie Therapies Corp. - Pipeline Products by Mechanism of Action, 2015
Biotie Therapies Corp. - Recent Pipeline Updates, 2015
Biotie Therapies Corp. - Dormant Developmental Projects,2015
Biotie Therapies Corp. - Discontinued Pipeline Products, 2015
Biotie Therapies Corp., Other Locations
Biotie Therapies Corp., Subsidiaries
List of Figures
Biotie Therapies Corp. - Pipeline by Top 10 Indication, 2015
Biotie Therapies Corp. - Pipeline by Stage of Development, 2015
Biotie Therapies Corp. - Monotherapy Products in Pipeline, 2015
Biotie Therapies Corp. - Pipeline by Top 10 Target, 2015
Biotie Therapies Corp. - Pipeline by Top 10 Route of Administration, 2015
Biotie Therapies Corp. - Pipeline by Top 10 Molecule Type, 2015
Biotie Therapies Corp. - Pipeline Products by Top 10 Mechanism of Action, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report